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Abstract 
Background: Self-rating instruments which require a large number of repeated assessments over time are increas-
ingly popular in psychiatry. They are well suited to describing variations in mental states, especially in order to investi-
gate effects of behaviour and events on functioning and mood. For bipolar disorder, the self-rating instrument ‘NIMH 
daily life chart’ was developed to assess the course of the illness. This instrument has been validated in the customary 
ways, yet information about data quality (e.g. completeness, consistency, construct validity, reactivity) was lacking. The 
goal of this study was to develop several data quality indicators computed from data, in order to be able to detect 
respondents that provide less valid or reliable data.
Methods: During approximately 1 year on average, 137 patients with DSM-IV diagnosed bipolar disorder rated their 
mood, functioning and number of alcohol units consumed on a daily basis. Three kinds of quality indicators were 
developed: (1) compliance (i.e. completeness of recording on a daily basis), (2) the association between conceptually 
related variables—construct validity—and (3) reactivity: any changes in alcohol-drinking behaviour due to the assess-
ments themselves. Relations were measured with Spearman’s rho.
Results: A relation was found between data quality and illness severity: respondents with lower data quality, accord-
ing to our operationalisations, were more strongly affected by the illness, as expressed in the number of ill days, than 
respondents with higher data quality.
Conclusion: The more affected patients are by the illness, the lower the data quality to be expected in life chart 
reports.
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Background
Assessing the course of bipolar disorder
Bipolar disorder (BD) is a serious, recurrent mental ill-
ness, characterised by mood swings that vary in their 
duration and frequency between manic, depressive and 
euthymic states. The illness has a variety of forms, with 
several subtypes of mania and depression (e.g. hypoma-
nia, severe mania, major depression, and minor depres-
sion). Initial diagnosis of bipolar disorder is difficult, 
and often occurs 5–10  years after the onset of the first 
symptoms [1]. This delay in diagnosis is caused by the 
variability of symptoms, phases and subtypes. In addi-
tion, BD is accompanied by high comorbidity of other 
syndromes, such as alcohol use and personality disor-
ders. More systematic insight in such illness variations 
is needed to provide a good descriptive base for clinical 
phenomenology. This requires flexible and comprehensive 
research methods. The variation in illness presentations 
initially hampered the development of sound research 
designs (clinical trials, longitudinal surveys) for study-
ing the course of BD. To overcome this problem, several 
authors [1–3] have argued that to study the varieties in the 
course of BD in a valid and reliable manner, fine-grained 
longitudinal assessment methods are required. To identify 
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and compare subtle mood changes, reports are necessary 
with respect to the severity of symptoms and risk factors 
on a prospective day-to-day basis, either through patient 
self-ratings or by clinician evaluations [4]. For example, 
to study the short-term effects of changes in alcohol use 
on illness severity, daily observations of alcohol consump-
tion and illness severity are required [5]. Also, prospec-
tive daily self-ratings enable the study of within-person 
processes over time and suffer less from recall bias as 
found in retrospective ratings [6]. In this manner, better 
understanding and management of disease development 
within patients with BD can be attained [2]. The choice 
for daily prospective monitoring, instead of hourly or 
weekly, is also supported by the finding that the circa-
dian rhythm and associated variables (e.g. hours of sleep) 
greatly influence cycle acceleration and mood change 
in bipolar disorder [7]. To enable fine-grained analysis 
of mood swings, the Stanley Foundation Bipolar Net-
work group used the National Institute of Mental Health 
prospective Life Chart Methodology (LCM), to record 
behaviour and illness symptoms [1, 8]. The LCM uses 
day-to-day self-ratings, since this allows for the descrip-
tion of the severity, frequency, duration and episodic pat-
terns of affective functioning of the patient. When daily 
LCM ratings are used, mood swings can be recognized at 
an early stage and it is possible to adapt treatment to the 
individual disease pattern. Within the LCM, with respect 
to illness symptoms, each day is characterized in terms 
of the severity of manic and depressive symptoms, on the 
basis of mood-related functional impairment in patients’ 
usual educational, social or occupational roles. Moreover, 
other relevant context variables, such as medication use, 
behaviours (including consumption behaviours), feelings 
and life events, are recorded daily. In this manner, daily 
mental processes in interaction with contextual features 
can be studied. The inclusion of several domains enables 
the study of patterns of co-variation in time between dif-
ferent variables. Initially, the Life Chart was developed as 
a clinical tool to assist patients and clinicians with dis-
ease management. Gradually, it has become an important 
instrument for assessing BD characteristics scientifically, 
as expressed in a growing number of publications that fea-
ture the instrument [3, 9–14]. Good psychometric quality 
of the LCM was demonstrated in several studies, includ-
ing interrater reliabilities of the instrument by different 
clinicians and high correlations with well-known cross-
sectional rating scales such as the Inventory of Depressive 
Symptomatology-clinician-rated (IDS-C) and the Young 
Manic Rating scale (YMRS) [15, 16].
Data quality of bipolar disorder assessments
This study concerns the data quality of the LCM. Data 
quality can be defined as the state of completeness, validity, 
consistency, and accuracy that makes data appropriate for 
a specific use. The issue of the data quality of self-ratings 
is an important one: Kessler [17] points to the assumption 
that self-ratings are subject to greater error than clinician 
judgments in diagnostic interviews. In an interview, the 
interviewer can serve as a tool to help respondents over-
come difficulties with respect to e.g. comprehension and 
interpretation of concepts. Self-rating instruments like 
the LCM rely on respondents’ own judgments and inter-
pretations. In the field of survey research, there is a tradi-
tion of investigating and publishing about data quality and 
measurement error [18–20]. However, studies on data 
quality of daily observation instruments are scarce. Some 
research concerning data quality has been published with 
respect to comparable self-rating monitoring instruments 
in psychiatry, e.g. the Experience Sampling Method (ESM), 
which can also be used to study dynamic mood changes 
over time and the situational determinants thereof [21], 
and the Ecological Momentary Assessment (EMA) [22]. 
These authors address several threats to data quality. For 
instance, lack of compliance with the research protocol 
may result in hoarding and backfilling, especially when 
paper-and-pencil instruments are used. Also, the intru-
siveness of the method can result in induced, rather than 
recorded, experiences. Socially desirable answering may 
occur, especially when task difficulty is high. Daily self-
ratings provide valuable, detailed information, yet the data 
gathering process may be hampered by specific complexi-
ties. Several advantages of illness data gathered using self-
monitoring instruments on a prospective daily base are 
also reported in the literature [2]:
1. They provide illness information that is usually una-
vailable in a hospital or GP’s records.
2. Daily reporting reduces retrospective recall bias, since 
it puts less strain on remembering processes.
3. Events from different domains and contexts can be 
related to each other, enhancing ecological validity 
[23].
4. Information provided by the patient will be more com-
plete than information in retrospective reports.
However, some disadvantages have been mentioned 
too:
1. Daily reporting of behaviour or feelings requires 
commitment and may be experienced as a burden-
some recurrent task resulting in less compliance, 
expressed in larger numbers of item non-response, 
dropout or decreasing compliance rates over time, 
resulting in missing data [2]. As such, a longer regis-
tration period may be harmful to data quality, since it 
invites respondents to sloppy registration [24].
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2. The task burden may be relieved by not reporting on 
a daily base (as required), but on estimations after 
a certain number of days; this is called “backfilling” 
[22].
3. Reactivity may occur, concerning a change in the 
behaviours under study, due to the measurement 
process itself. The awareness of behaviours or psy-
chological states to which patients are otherwise 
inattentive may alter the behaviour under study in a 
socially desirable way [25].
4. Self-presentation tendencies such as socially desir-
able reporting can occur, for example underreporting 
of systematic alcohol use by heavy drinkers [26].
Aim of this study
Until now no systematic empirical evaluation of data 
quality regarding the LCM instrument exists. The pre-
sent study evaluates and compares possible data quality 
indicators for the LCM life chart instrument. Quality 
indicators are constructed and their performance and 
significance are evaluated, for example by identify-




A total of 180 outpatients were approached at 13 Dutch 
mental health treatment centres and at the Dutch Asso-
ciation for Manic-Depressive Patients and Relatives 
(DAMDR). Of these, 158 patients (88 %) entered baseline 
assessment. Subjects were asked to fill out the prospec-
tive life charts daily for a period of at least a year, during 
which monthly clinician visits were also planned. During 
these visits, clinician and patient discussed the life chart 
data of the previous month, after which these life chart 
registrations were approved. Of the 158 patients who 
completed the baseline assessment, 137 subjects (87  %) 
participated in the study for at least 2 months. The analy-
ses in this study are based on these 137 subjects, which 
enables comparison of the data quality of persons with 
long and short registration periods. A minimal observa-
tion period of 2 months was chosen since a variation in 
the length of the recording period can be expected among 
daily-reporting studies, as reflected in compliance. An 
observation period of less than 2 months was considered 
problematic for studying variation. Only one person pro-
vided a life chart of one month, which was moreover only 
partially filled out. Of the 137 patients who completed 
two or more life charts, 124 patients (91 %) participated 
for at least 6 months, and 83 patients (61 %) completed 
at least a whole year, i.e. 365 days or more. Reasons for 
non-completion beyond 6 months were: aversion to the 
daily registrations, developing a severe depressive or 
manic episode, worsening of alcohol dependence, death 
(n = 2) and other reasons. The sample is described more 
extensively elsewhere [5]. The study was approved by 
the Medical Ethical Review Committee of the University 
Medical Center Utrecht (The Netherlands). All patients 
gave written informed consent after the aims of the study 
were explained to them (mainly, obtaining insight into 
the relation between substance use and illness course).
Data collection: instruments
1. At entry, the Structured Clinical Interview for DSM-
IV (SCID-I) was administered by trained mental 
health care professionals in order to establish the 
diagnosis of bipolar disorder in a reliable manner.
2. The LCM used for the present study is a paper-and-
pencil instrument, consisting of an A3-size page on 
which relevant information can be recorded during a 
period of 31  days. Behaviour domains are: hours of 
sleep; alcohol, cigarette, coffee, tea and cola use; can-
nabis intake, and medication use. Space is available 
for recording important life events. Mental states 
are assessed by two separate scores: (1) illness sever-
ity scores (range −10 to +10) and (2) mood scores 
(range 0–100). The instruction to patients regarding 
experienced illness severity prescribes that “severity 
is based on your level of functional impairment due 
to depressive or manic mood symptoms in your usual 
social, educational, and occupational roles”. Hospital-
ization for mania or depression is rated at the most 
severe level of plus or minus 10. Severity reporting is 
set out in Fig. 1.
 Episodes of depression are indicated below a baseline 
in the chart at four levels (mild, low moderate, high 
moderate or severe) and mania is indicated above 
these lines, using the same four levels. In the middle 
is the baseline, which indicates a euthymic level or 
balanced mood state (not depressed or manic). Daily 
illness severity scores range from 0 (euthymic or nor-
mal) through 2.5 (minimally ill), 5 (low moderate), 
and 7.5 (high moderate) to 10 (severely ill). Depres-
sive symptom severity scores are indicated by nega-
tive scores, manic symptoms with positive scores. 
Thus, the severity variable can reach scores from 
minus 10 to plus 10, with intervals of 2.5. Mood scor-
ing is described in the introduction as follows: “The 
mood scale assists you in rating your mood in fine 
gradations: the scale is from 0 to 100 (0 =  the most 
depressed you could imagine being; 50 = a balanced 
or level mood; 100 =  the most energetic/activated/
manic you could ever be)”. Severity scores are sup-
posed to indicate ‘functioning’, whereas the mood 
score reflects ‘feeling’. Patients were also asked to 
report daily on their alcohol use (number of alcohol 
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Fig. 1 Example of aNIMH daily life chart form. Daily consumption of medicine and possibly drugs, drinks at the top of the chart, daily rating of 
functioning and mood at the bottom
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units), for which patients received written and verbal 
instructions concerning the standard units of alcohol 
in beer, wine and spirits. Negative effects of alcohol 
use on BD illness severity are well documented [5]. 
It is therefore relevant to investigate whether a mod-
erator effect on the relation between alcohol use and 
illness severity on account of data quality indica-
tors exists. To this end, the dataset described in van 
Zaane et al. [5] is used to establish and investigate the 
effects of quality indicators.
 At baseline and at every monthly visit during fol-
low-up, the LCM registrations were checked and 
approved by research assistants. Patients were 
requested to register their symptom severity, mood 
and actual alcohol use every day for a period of at 
least 12 months. More than half of the sample kept 
life charts for more than 12 months.
3. Furthermore, during monthly visits clinicians rated 
the functioning or illness severity of the respondents 
over the preceding week using the CGI-BP (Clini-
cal Global Impression Scale-Bipolar Version [27, 
28]). The CGI-BP requires the clinician to rate the 
severity of the disorder during the preceding week 
on a seven-point scale, in which 1 denotes ‘not at 
all ill’ and 7 denotes ‘very severely ill’. All clinicians 
were trained in establishing CGI scores. Mania and 
depression were rated separately in this CGI-BP, 
resulting in two separate variables. A total of 3288 
CQI ratings (137 × 12 × 2) was possible. However, 
14 % (N = 460) missing values were present in these 
ratings.
Variables
Several types of variables were discerned:
1. Demographic variables, such as age at enrolment, 
gender and education.
2. Clinical variables, divided into apparent—i.e. directly 
observed—and constructed variables. Apparent vari-
ables are the daily reported number of alcohol con-
sumptions, mood score, and illness severity score. 
Also, monthly CGI scores provided by the clinician 
were used as apparent variables: one for mania and 
another for depression, ranging from one to seven. 
Constructed clinical variables (used as outcome 
measures) are the ‘total numbers of ill days in a year’ 
and ‘number of illness episodes’ based on DSM IV 
criteria. An ill day was defined as a day with a manic 
illness severity score of at least mild mania (severity 
score 2.5 or higher) or a score of at least moderate 
depression (score −5 or lower). The total numbers of 
ill days was transformed into a proportion of the total 
observation period. A manic episode consisted of at 
least 7 days of moderate mania (score 5 or higher), a 
hypomanic episode of at least 4 days of mild mania 
(score 2.5 or higher), and a depressive episode of at 
least 14  days of moderate depression (score 5 or 
lower). The experienced numbers of episodes were 
corrected for number of observations.
3. Quality indicators, constructed using the abovemen-
tioned variables. Their definition and operationalisa-
tion are described in the next section.
Quality indicators
For our purpose, a requirement for quality indicators 
is that their values can be established using the data at 
hand. Three data quality concepts are used in relation to 
the dataset obtained with the LCM life chart:
1. Compliance Compliance, i.e. recording on a daily 
basis, can be defined as a compound concept con-
sisting of two constituents. The first constituent is 
the number of days for which reports are available 
(length of observation period). The second is the per-
centage of missing data (item non-response) within 
the observation period.
2. Consistency Biemer and Lyberg [18] mention internal 
consistency checks for the assessment of data qual-
ity, which may take several forms. In our study, two 
operationalisations of consistency were possible and 
were used.
 – A strong association between conceptually related 
variables was expected. In the present study, this 
was translated into the expectation of a posi-
tive strong association between illness severity 
and mood ratings (i.e. severity scores and mood 
scores). These two kinds of self-reporting scores are 
recorded in the LCM daily (see Fig. 1).
  – Also, judgment scores on the same variables 
obtained from the clinician or by means of self-rat-
ing instruments should correlate strongly [16, 29], 
indicating adequate construct validity. We expected 
a relation between the CGI-BP clinician scores 
on mania and depression for the preceding week 
obtained monthly and the daily reports for that 
same week by the patient.
3. Reactive effects These concern the fact that screen-
ing and assessment affect behaviour under study. 
A change in reporting of sensitive behaviour in 
the desirable direction as a result of the fact that 
the behaviour should be reported is often seen in 
research as well as in treatment. The evidence for a 
reactivity effect pertaining to alcohol use is precari-
ous [25]. Sometimes only an effect of assessments on 
binge drinking or risky drinking behaviour is found, 
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and not on overall drinking volume. Johnson et al. [2] 
assessed behaviour, environment, contexts and mood 
in an ambulatory monitoring set-up for patients with 
schizophrenia, anxiety or substance dependence 
and controls, and found that the majority of vari-
ables investigated did not change in frequency as a 
function of study duration. However, some evidence 
was found that socially sensitive behaviours—such 
as self-care behaviour—changed in a manner con-
sistent with reactivity. However, in most studies the 
number of assessments is lower than ten and not 
fine-grained. In our study, which uses daily ratings, it 
may be expected that the initial registration of alco-
hol use will suffer from reactivity: some respondents 
may report less alcohol use after the first week of 
alcohol reporting, as a result of growing awareness 
of their alcohol consumption. However, this reactiv-
ity is expected to diminish after a while, due to the 
rather long duration of the recording period and the 
assumed chronic nature of patterns of alcohol con-
sumption. Patients will probably not be able to main-
tain lower levels of alcohol consumption than are 
usual for them for such a long period.
Procedures for data quality indicators
For each indicator, values in the continuum between zero 
(extremely low data quality) and one (perfect data qual-
ity) are established per case. This enables comparison 
between indicators. To accomplish this, the following 
general transformation algorithm for the raw quality indi-
cator scores was used: transformation from range Xmin 
to Xmax to a range of Ymin to Ymax: Yi = [(Xi − Xmin)/
(Xmax − Xmin)] × (Ymax − Ymin) + Ymin. Ymin takes 
on the value of 0, and Ymax the value of 1, whereas the X 
values are the original values of the indicators.
Compliance
(A)  Using the transformation algorithm, the lengths 
of the individual observation periods were estab-
lished and transformed into scores ranging from 0 
(shortest observation period, 62  days) to 1 (long-
est observation period, 529  days). As an illus-
tration, the algorithm used for the observation 
period is: index value  =  [(individual observation 
period − 62)/(529 − 62)]*[(1 − 0) + 0]. The result 
for an observation period of 100  days would be 
0.08 and for 200 days 0.3.
(B)  The ‘missing observations percentage’ could be 
established for the whole observation period 
(observed range: 0–30  %). The percentages were 
transformed into a scale from 0 (largest percentage 
of missing observations within the whole observa-
tion period) to 1 (no missing observations).
Consistency
(A)  A correspondence between daily mood scores and 
daily severity ratings was expected. Individual cor-
relations between the daily mood and severity scores 
were calculated and translated into a scale from 0 
(lowest correlation) to 1 (perfect correlation).
(B)  During monthly clinician visits, illness severity was 
established using the CGI. The severity of depres-
sion score—ranging from 1 (normal, not at all ill) 
to 7 (extremely ill)—and the severity of mania 
score were used. Patients’ daily ratings of mania 
and depression severity were averaged for the 
same seven weekdays as those on which the clini-
cian score was based. Correlations were calculated 
between the scores of the total series of monthly 
visits in which CGI scores were established and 
the series of severity scores of the weeks preceding 
the visits, if available. Individual correlations were 
transformed to a scale from 0 (lowest correlation 
between clinician judgment and self-report) to 1 
(perfect correlation between clinician judgment 
and self-report), using the algorithm mentioned 
above.
Reactivity
Behaviour change due to the measurement process itself 
was operationalised as follows. The average number of 
alcoholic drinks for week number 4 was subtracted from 
those for week number 1. Positive differences indicate a 
reactivity effect: the person has diminished the number 
of drinks consumed. Negative differences indicate an 
increase in consumed alcohol. The largest positive differ-
ence was translated into 0 (maximum reactivity), and the 
largest negative difference into 1 (least reactivity).
Statistical analyses
For summary statistics, means and standard deviations 
were calculated for continuous variables; counts and per-
centages for discrete variables. Since the distributions 
of the indices were not normal, associations between 
different quality indicators, between quality indicators 
and dependent variables (illness-related variables), and 
between quality indicators and patients’ background 
characteristics were calculated using bivariate Spear-
man’s rho. In case of missing values on indicators, list 
wise deletion was used in calculations. Linear regression 
was conducted using quality indicators as continuous 
predictor variables and the proportion of ill days in the 
observation period as outcome variable.
Results
In Table  1, the sample of patients is characterised with 
demographic and clinical information.
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The average age in the sample was 45.9 years (SD 10.2), 
53 % was male, 49 % had a partner, 62 % had an income 
lower than 20,000 euros and 47  % had an education 
below high-school level. Table 2 provides descriptives of 
the quality indicators.
In the top row, raw scores are presented; in the second 
row descriptives of the transformed indicators, ranging 
from 0 to 1. The least variation was found on the indi-
cators ‘missings percentage’ and ‘reactivity’. Only 35  % 
of the sample had missing data points during the entire 
observation period, and the average percentage was low. 
With regard to reactivity in alcohol consumption, the dif-
ferences in average number of drinks between weeks 1 
and 4 were normally distributed—about equal numbers 
of patients decreased or increased their alcohol con-
sumption in the first 4  weeks. Of the forty respondents 
who scored below the average of 0.74 on the reactivity 
indicator, twelve increased their drinking in weeks 5–7. 
Hence, it can be argued that clear-cut reactivity is not 
present in this sample with regard to self-reported daily 
alcohol consumption.
As can be seen in Table 3, the number of significant cor-
relations between quality indicators was moderate: only 
three correlations attained significance. They concern cor-
respondences between related constructs: correspondence 
between patient and clinician judgment about functioning 
in term of depression and mania, and correspondence 
between self-rated daily mood and severity scores. Most 
of the significant relations are found for consistency, dem-
onstrating that consistency is the best indicator. Again, 
reactivity and missings percentage scored lowest of the six 
indicators. Associations between quality indicators and 
four outcome variables—the proportions of ill days in the 
observation period and the numbers of depressive, manic 
and hypomanic episodes—are presented in Table 4.
Seventeen of the twenty-four correlations have nega-
tive signs, indicating that a lower data quality obtains 
when values for the dependent variables (indicators of 
illness) increase. Only four significant correlations are 
found on the outcome variables, ranging from −0.19 to 
−0.50 (4–25 % variance explained). The higher the scores 
on quality indicators, the smaller the number of ill days 
and ill episodes experienced; lower data quality obtains 
for patients with relatively large numbers of ill days and 
manic or depressive episodes. A regression analysis was 
performed on the number of ill days, using the quality 
indicators as predictors after natural log transformation; 
the results are shown in Table 5.
Five of the six betas are negative; the higher the value 
of the data quality indicator, the lower the number of ill 
days that the patient experiences. Only two betas (miss-
ings % and LC depression-CGI-BP) reach significance.
Finally, relations between quality indicators and back-
ground characteristics are presented in Table 6.
Positive correlations in Table  6 indicate higher data 
quality. For example, older persons have higher values 
on the ‘correlation between LC depression and clinician 
judgment depression’ quality indicator. People with lower 
incomes and younger people are relatively sensitive to 
reactivity with regard to alcohol consumption.
Conclusion
We have found weak effects: up to twenty-five per cent 
explained variance of the constructed quality indica-
tors for daily prospective self-ratings concerning disease 
course. The main conclusion is that the more affected the 
patient is in terms of experienced number of ill days and 
manic and depressive episodes, the lower the data quality 
will be.
Discussion
The results could be interpreted as follows: it is sensible 
to handle self-ratings of rather ill respondents with cau-
tion, as patients heavily affected by mood symptoms are 
‘worse daily raters’. Researchers should be aware of the 
fact that the more severe patients’ bipolar disorder is, the 
less valid or reliable self-ratings will be. The effects found 
in terms of explained variance are low to moderate: this 
may on the one hand indicate that the quality of this 





Mean ± SD Type BD disorder Total (%)
Age, years 45.9 ± 10.2 Bipolar I 90 (65.7)
Bipolar II 47 (34.3)
Total (%) Mean ± SD
Gender Duration bipolar 
disorder, years
21.7 ± 11.5
 Male 72 (53)
 Female 65 (47)




 With partner 67 (49) No. of episodes
 Without partner 69 (50) Depression 15.3 ± 23.4
 Unknown 1 (1) (Hypo)mania 13.8 ± 21.5
Annual income N of hospitalisations
 <20,000 € 82 (62) Depression 0.9 ± 2.1
 ≥20,000 € 50 (38) (Hypo)mania 1.3 ± 2.3
Educational level
 ≤High school 65 (47)
 >High school 71 (52)
 Unknown 1 (1)
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dataset is adequate; on the other hand, the indicators are 
informative, since they do explain some variation.
This specific sample may have had some character-
istics that influenced the results: patients were rather 
compliant in filling out the LCM, which is expressed 
in low percentages for missing data points. The aver-
age disease length was about 22  years (Table  1), 
which is rather long. Patients in this sample have a 
low chance of recovery; their situation can best be 
described as ‘stable’. Since most members of the sam-
ple were also adherent to therapy and motivated (48 
patients were members of the DAMDR), on entering 
the study a self-selection effect may have occurred. 
This means that in other samples the compliance indi-
cators may score worse and may have stronger rela-
tions to disease outcome variables. New developments 
in life charts for bipolar patients involve electronic 
recording via the web. This electronic data collec-
tion instrument provides the option of monitoring 
the exact dates and times of recording. The result that 
the association between self rating and clinician CGI 
rating of depression are negatively related to illness 
severity has a clinical implication: the more patient 
and clinician agree with respect to depression ratings, 
the smaller the number of self reported ill days. Also, 
when it is difficult to obtain self ratings for a long 
observation period, this can be an indication that the 
patient is severely ill.
Limitations of this study concern the fact that data 
quality indicators were newly developed: no existing 
operationalisations were available. For example, it is not 
clear whether the indicator reactivity, a reported change 
in alcohol use consumption in the first four weeks repre-
sents a real change in sensitive behaviour or underreport-
ing of the actually consumed number of alcohol units. 
However, in a previous publication [3] we also observed 
Table 3 Spearman’s rank order correlations between quality indicators













Observation length 1 – – – – –
Missings % 0.14 1 – – – –
LC depression-CGIBP 0.09 0.05 1 – – –
LC mania-CGI-BP −0.03 0.05 0.53** 1 – –
LC mood-LC severity 0.01 0.13 0.41** 0.33** 1
Alcohol consumption 
week 1–4
0.02 0.07 −0.07 −0.10 −0.04 1
Table 4 Spearman’s rank order correlations of quality indicators with dependent variables (illness indicators)
* Significant at level p < 0.05
** Significant at level p < 0.01
Observation  
length








Proportion of ill days −0.10 −0.10 −0.36** −0.19* −0.13 −0.04
No. of depressive episodes 0.02 −0.00 −0.01 0.10 −0.05 −0.00
No. of manic episodes 0.05 −0.03 0.09 −0.10 0.02 −0.05
No. of hypomanic  
episodes
0.09 −0.14 −0.28** −0.50** −0.11 0.04
Table 5 Regression of  quality indicators on  number of  ill 
days
Standardised beta p value
Observation length −0.23 0.02
Missings % −0.10 0.33
LC depression-CGI-BP −0.29 0.02
LC mania-CGI-BP −0.09 0.37
LC mood-LC severity 0.11 0.31
Reactivity, alcohol −0.07 0.49
Adjusted R square: 0.11
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that a subgroup of heavy drinking patients in the sample 
studied, significantly reduced their alcohol consump-
tion in the follow up year as compared to the first four 
weeks of the observation period. This may indicate a real 
behaviour change in the long term. In this study we have 
chosen to use only the first four weeks of the observa-
tion period to assess immediate reactivity to self report-
ing of alcohol consumption. Replications of the use of 
comparable operationalisations can give more insight in 
the use of such indicators. Lastly, to establish inter-rater 
reliability of the ratings of patient functioning ratings of 
different clinicians would have been necessary. Yet this 
was impossible due to restrictions on costs and logistics 
of the study.
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